@article{155dad270c9447339d1fab366b6dd72b,
title = "First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series",
abstract = "We have conducted a series of four feasibility studies in stage Ic-IV ovarian cancer exploring six sequential first-line schedules with the same entry criteria in a total of 339 patients. Here we present the results of the sixth study, and an analysis of the overall series.",
keywords = "Carboplatin, Paclitaxel, Gemcitabine, Sequential therapy, Ovarian cancer",
author = "{Scottish Gynecological Cancers Trials Group} and Roshan Agarwal and Charles Gourley and Perren, {Timothy J} and Nicholas Reed and Parkin, {David E} and Karen Carty and Rustin, {Gordon J S} and Hani Gabra and Jim Paul and Gore, {Martin E} and Kaye, {Stanley B}",
note = "Copyright 2010 Elsevier Ltd. All rights reserved.",
year = "2010",
doi = "10.1016/j.ejca.2010.03.006",
language = "English",
volume = "46",
pages = "2020--6",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "PERGAMON-ELSEVIER SCIENCE LTD",
number = "11",
}